Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Publication year range
1.
Int J Tissue React ; 27(4): 181-8, 2005.
Article in English | MEDLINE | ID: mdl-16440583

ABSTRACT

Bone morphogenetic protein (BMP) is a unique cytokine that induces bony tissue in soft tissue. Tissue reactions at and around the implantation of recombinant human BMP-2 (rhBMP-2) into the soft tissue of rats and nonhuman primates were investigated. At the osteoinduced site of rats, massive trabeculae-lined osteoblasts and rich marrow were observed. At and around the nonosteoinduced sites of nonhuman primates, large clear nuclei were observed in reaction to rhBMP-2 implantation. The surrounding area was visually classified into zones 1, 2 and 3. Zone 3 was near the center of the implant. The area of nuclei, the major axis, the minor axis and the ratio of minor axis per major axis were image-analyzed in the histological views. In zones 1, 2 and 3, the nuclear areas were 18.0 (3.1) mean (SD); unit micron2, 33.4 (5.61) and 110.1 (23.7), respectively. The major axes of nuclear ellipses were 7.45 (0.22) (unit micron), 7.76 (0.26), and 13.9 (1.88), respectively. The minor axes were 3.07 (0.53), 5.59 (0.95) and 10.1 (1.35), respectively. The ratios of minor axis per major axis of nuclear ellipses were 0.4 (0.57), 0.72 (0.11) and 0.73 (0.11) in zones 1, 2 and 3, respectively. These results showed that in zones 2 and 3 cell and tissue reactions were marked against rhBMP-2 implantation.


Subject(s)
Bone Morphogenetic Proteins/administration & dosage , Bone Morphogenetic Proteins/metabolism , Muscle, Skeletal/metabolism , Recombinant Proteins/administration & dosage , Recombinant Proteins/metabolism , Transforming Growth Factor beta/administration & dosage , Transforming Growth Factor beta/metabolism , Animals , Bone Morphogenetic Protein 2 , Bone and Bones/chemistry , Bone and Bones/cytology , Bone and Bones/metabolism , Drug Implants , Humans , Macaca , Male , Muscle Cells/chemistry , Muscle Cells/cytology , Muscle Cells/metabolism , Muscle, Skeletal/chemistry , Muscle, Skeletal/cytology , Osteoblasts/chemistry , Osteoblasts/cytology , Osteoblasts/metabolism , Osteogenesis/drug effects , Rats , Rats, Wistar
2.
Intern Med ; 40(9): 915-9, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11579956

ABSTRACT

A 38-year-old man presented with headache, fever, and double vision associated with right abducens nerve paresis. He had neither nuchal rigidity nor visual field defect. Laboratory data revealed elevated erythrocyte sedimentation rate (ESR), eosinophilia, and lymphocytic pleocytosis in the cerebrospinal fluid (CSF). Provocation tests of pituitary hormones showed partial hypopituitarism. Magnetic resonance imaging (MRI) revealed swelling of the hypophysis and a mass lesion expanding into the right cavernous sinus. The supplement dose of dexamethasone for hypothalamic hypocortisolism manifested diabetes insipidus. Biopsy, carried out through the transsphenoidal approach, revealed giant cell granuloma. Systemic granulomatous diseases were ruled out, and the lesion was considered to be idiopathic giant cell granulomatous hypophysitis. Right abducens nerve paresis, diabetes insipidus and dysfunction of the anterior lobe were amended by the treatment with prednisolone for 4 months, and findings of the pituitary gland and stalk were normalized. The present case shows that glucocorticoid has an effect on amendment of idiopathic giant cell granulomatous hypophysitis.


Subject(s)
Abducens Nerve Diseases/etiology , Diabetes Insipidus/etiology , Granuloma, Giant Cell/complications , Hypopituitarism/etiology , Pituitary Diseases/complications , Abducens Nerve Diseases/blood , Abducens Nerve Diseases/drug therapy , Adult , Anti-Inflammatory Agents/therapeutic use , Diabetes Insipidus/blood , Diabetes Insipidus/drug therapy , Granuloma, Giant Cell/blood , Granuloma, Giant Cell/drug therapy , Humans , Hypopituitarism/blood , Hypopituitarism/drug therapy , Male , Pituitary Diseases/blood , Pituitary Diseases/drug therapy , Prednisolone/therapeutic use , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL